Form 8-K Axsome Therapeutics, For: Dec 31

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. TMUS
7. SPY
8. CVS
9. UNH
10. SBUX

Go back to Form 8-K Axsome Therapeutics, For: Dec 31

Baird on Axsome Therapeutics (AXSM): 'Incrementally positive on regulatory updates'

December 31, 2025 1:54 PM EST

Baird analyst Joel Beatty reiterated an Outperform rating and $157.00 price target on Axsome Therapeutics (NASDAQ: AXSM).

The analyst comments "Incrementally positive on regulatory updates. Axsome announced two New Year's Eve regulatory updates, with their sNDA for AXS-05 (Auvelity) in Alzheimer's agitation... More

Leerink on Axsome Therapeutics (AXSM): 'This is very positive news'

December 31, 2025 1:20 PM EST

Leerink Partners analyst Marc Goodman reiterated an Outperform rating and $150.00 price target on Axsome Therapeutics (NASDAQ: AXSM).

The analyst comments "This is very positive news for Axsome, as Alzheimer's disease agitation (AD-A) is a key additional indication to drive... More

Axsome Therapeutics (AXSM) PT Raised to $169 at Needham

December 31, 2025 8:27 AM EST

Needham analyst Ami Fadia raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $169.00 (from $154.00) while maintaining a Buy rating.

... More